Osteoporosis: A review of current recommendations and emerging treatment options; Focus On Dapagliflozin: An emerging treatment option for type 2 diabetes mellitus
Novo Nordisk Terminates Collaboration with Hims & Hers
June 23rd 2025The FDA had resolved the shortage of Wegovy in April, and telehealth providers were advised to stop selling compounded semaglutide products. Novo Nordisk said that Hims & Hers continues to offer these compounded drugs.
Read More